Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Atopic Dermatitis: full-pipeline trial registry
55 of 151 indexed Atopic Dermatitis trials are currently recruiting.
Corpus placement: #76 of 28,707 conditions by registered trial count.
151 US clinical trials · 55 currently recruiting · #76 of 28,707 conditions by registered trial count
Atopic Dermatitis: 151 US clinical trials tracked, 55 recruiting.
Atopic Dermatitis is the subject of 151 registered US clinical trials on ClinicalTrials.gov, 55 of them currently open to new participants. 47 are in Phase 3-4 (later-stage) and 66 in Phase 1-2 (earlier-stage). The most active sponsor is Pfizer, running 10 of these trials.
Enrollment posture brief
Registry condition atopic-dermatitis
OPEN 55 | RECR 36% | LATE 47 | EARLY 66 | RANK #76 | SPON 10
Volume-matched condition peers
Nearest open-share peer: Acquired Brain Injury (36% recruiting · 11 trials)
Atopic Dermatitis lists 55 open slots (36% of 151 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Atopic Dermatitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Atopic Dermatitis recruits in line with its size-band peers.
55 of 151 indexed trials (36.4%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Atopic Dermatitis trials is spread across many organizations.
Pfizer accounts for 10 of 151 trials (6.6%). 80 distinct sponsors appear on at least one study for this condition label.
-
Typical Atopic Dermatitis enrolment sits around 137 participants.
Median target enrolment is 137 among the 151 trials that report a genuine target (sentinel values excluded). 65 of those (43%) plan for fewer than 100 participants.
-
Atopic Dermatitis research is mostly interventional.
122 interventional and 29 observational studies make up this index (80.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 48 |
| Phase 3 | 28 |
| Phase 4 | 19 |
Top Sponsors
Named interventions
Most-linked intervention names on Atopic Dermatitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Atopic Dermatitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Atopic Dermatitis page
151 registered trials, 55 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 55 Atopic Dermatitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Pfizer sponsors the most Atopic Dermatitis trials on record, review their full trial history before evaluating a specific study. See Pfizer's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Atopic Dermatitis condition card totals 151 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.